Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Stem Cells Publisher



Khatami F1 ; Aghaii M1 ; Tehrani FD2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran

Source: Stem Cells in Urology Published:2020


Abstract

Cancer Stem Cells (CSCs) are a minor group of cells in tumors that have self-renewal, differentiation, and tumorigenicity properties. Some known markers such as CD44, CD24, and CD133 on the cell membrane are often used to identify and enrich CSCs in several tumors, including prostate tumors, testis tumors, kidney cancers, and bladder tumors. Actually, CSCs can pass through vessels and shed into the blood and circulate freely to form circulating tumor cells (CTCs). CTCs are suggested as the real-time representers of the tumor. They are the main component of liquid biopsy together with cell free DNA (cfDNA) and exosomes, which are important diagnostic and prognostic markers in uro-oncology. Currently, numerous studies are about the isolation of CSCs from cancers of genito-urinary tracts, especially in prostate, urothelial and kidney cancer origin. Tumor’s progress reveals new ways of finding more effective treatment strategies. In this book chapter, we summarize the current understanding of CSCs and explain the current achievements in cancer stem cell research in urological malignancies. © Springer Nature Switzerland AG 2020.
Related Docs
View other Related Docs
1. Regenerative Medicine in Urology, Stem Cells in Urology (2020)
2. Competing Endogenous Rnas Regulatory Crosstalk Networks: The Messages From the Rna World to Signaling Pathways Directing Cancer Stem Cell Development, Heliyon (2024)
3. Introduction, Stem Cells in Urology (2020)
4. Current Approaches in Identification and Isolation of Cancer Stem Cells, Journal of Cellular Physiology (2019)
5. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
6. Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review, International Journal of Stem Cells (2019)
7. Update on Immune-Based Therapy Strategies Targeting Cancer Stem Cells, Cancer Medicine (2023)
8. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Kazem Aghamir Mohammad Ali (9)
Arezoo Rasti (6)
Other Related Docs
9. Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics, Frontiers in Oncology (2019)
10. A New Insight Into Cancer Stem Cell Markers: Could Local and Circulating Cancer Stem Cell Markers Correlate in Colorectal Cancer?, Tumor Biology (2016)
11. Tumor Immunology, Clinical Immunology (2022)
12. Liquid Biopsy As a New Tool for Diagnosis, Monitoring, and Personalized Medicine in Urogenital Cancers, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
13. Circulating Tumor Cells and Dnas in Prostate Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
14. Identification of Placenta-Specific Protein 1 (Plac-1) Expression on Human Pc-3 Cell Line-Derived Prostate Cancer Stem Cells Compared to the Tumor Parental Cells, Discover Oncology (2024)
15. Increased Expression of Cd44 Is Associated With More Aggressive Behavior in Clear Cell Renal Cell Carcinoma, Biomarkers in Medicine (2018)
16. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
17. Glance Into Cancer Stem Cells, Journal of Kerman University of Medical Sciences (2016)
18. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
19. Cancer Stem Cell Research in Iran: Potentials and Challenges, Future Oncology (2017)
20. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
21. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
22. Local Immunotherapy of Glioblastoma: A Comprehensive Review of the Concept, Journal of Neuroimmunology (2023)
23. U-Shape Incision on Prostate Capsule: New Intraperitoneal Laparoscopic Technique in Simple Prostatectomy: A Case Report, Annals of Medicine and Surgery (2021)
24. Cancer Stem Cell’S Potential Clinical Implications, International Journal of Cancer Management (2017)
25. Liquid Biopsy in Male Genital Tract: Testis Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
26. Deciphering Biological Characteristics of Tumorigenic Subpopulations in Human Colorectal Cancer Reveals Cellular Plasticity, Journal of Research in Medical Sciences (2016)
27. Increased Expression of Aldh1a1 in Prostate Cancer Is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients, Applied Immunohistochemistry and Molecular Morphology (2017)
28. Targeting the Metabolism of Cancer Stem Cells by Energy Disruptor Molecules, Critical Reviews in Oncology/Hematology (2022)
29. Glioblastoma Cancer Stem Cell Biology: Potential Theranostic Targets, Drug Resistance Updates (2019)
30. Human Telomerase Reverse Transcriptase Protein Expression Predicts Tumour Aggressiveness and Survival in Patients With Clear Cell Renal Cell Carcinoma, Pathology (2019)
31. Smad4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes, Frontiers in Oncology (2021)
32. Cytoplasmic Expression of Cd133 Stemness Marker Is Associated With Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma, Experimental and Molecular Pathology (2017)
33. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
34. Anticancer Properties of a New Platinum (Iv) Agent on Ht1080 Cancer Stem-Like Cells: An in Vitro Study, Acta Medica Iranica (2022)
35. Expression of Cd133 Cancer Stem Cell Marker in Melanoma: A Systematic Review and Meta-Analysis, International Journal of Biological Markers (2016)
36. Co-Expression of Putative Cancer Stem Cell Markers Cd44 and Cd133 in Prostate Carcinomas, Pathology and Oncology Research (2017)
37. The Potential Therapeutic Effect of Melatonin on Human Ovarian Cancer by Inhibition of Invasion and Migration of Cancer Stem Cells, Scientific Reports (2017)
38. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
39. Thyroid Cancer Research at Endocrinology and Metabolism Research Institute (Emri): A Report of Scientific Activities Between 2005 and 2020, Journal of Diabetes and Metabolic Disorders (2021)
40. The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer, Iranian Journal of Biotechnology (2022)
41. Micrornas and Long Non-Coding Rnas As Biomarkers for Polycystic Ovary Syndrome, Journal of Cellular and Molecular Medicine (2022)
42. Cancer Stem-Like Cell Behavior in Anaplastic Thyroid Cancer: A Challenging Dilemma, Life Sciences (2016)
43. The Molecular Signature of Breast Cancer Metastasis to Bone, Anti-Cancer Drugs (2016)
44. Immunopathology and Immunotherapy of Myeloid Leukemia, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
45. Upregulation of Circulating Cancer Stem Cell Marker, Dclk1 But Not Lgr5, in Chemoradiotherapy-Treated Colorectal Cancer Patients, Tumor Biology (2015)
46. Functionalised Nanomaterials for Eradication of Cscs, a Promising Approach for Overcoming Tumour Heterogeneity, Journal of Drug Targeting (2018)
47. Cancer Stem Cells and Oral Cancer: Insights Into Molecular Mechanisms and Therapeutic Approaches, Cancer Cell International (2020)
48. Investigation of Simvastatin-Induced Apoptosis and Cell Cycle Arrest in Cancer Stem Cells of Mcf-7, Journal of Cancer Research and Therapeutics (2016)
49. Transplant and Kidney Repair, Stem Cells in Urology (2020)
50. Molecular Docking As a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes, Frontiers in Pharmacology (2022)